← The Wire
MGNXNasdaq
MACROGENICS INC
Pharmaceutical Preparations · DE · CIK 1125345
Develops antibody-based cancer therapeutics, including ADCs and multi-specific antibodies
$252M
Market cap
$4.86
Last close
+1.0%
1D
+6.1%
5D
1.4M
Volume
Price · last 39 sessions+51.9%
May 4L $2.94 · H $4.86Jun 29
270
Total filings
May 20, 2026
Last filing
12/31
Fiscal year end
SC 13GSC 13GNov 20, 2024SC 13GSC 13GJun 4, 2024SC 13GSC 13GMay 21, 2024SC 13GSC 13GFeb 14, 2024SC 13GSC 13GOct 30, 2023SC 13GSC 13GFeb 14, 2023SC 13GSC 13GSep 2, 2022SC 13GMACROGENICS, INC.Feb 14, 2022SC 13GSC 13GFeb 4, 2022SC 13GSCHEDULE 13GFeb 16, 2021SC 13GSC 13GFeb 11, 2021SC 13GSCHEDULE 13GAug 21, 2020SC 13GSEC SCHEDULE 13GFeb 13, 2020SC 13GSC 13GJun 27, 2019SC 13GSC 13GMay 23, 2019SC 13GSC 13GFeb 14, 2019SC 13GSC 13GFeb 11, 2019SC 13GSC 13GJun 12, 2017SC 13GSC 13GDec 29, 2016SC 13GSCHEDULE 13GFeb 4, 2016SC 13GSC 13GJan 28, 2016SC 13GMACROGENICS SCHEDULE 13G 2-11-15Feb 12, 2015SC 13GSCHEDULE 13G FOR MACROGENICS, INC. BY JOHNSON & JOHNSONFeb 5, 2015SC 13GSC 13GApr 9, 2014SC 13GSC 13GFeb 14, 2014SC 13GSC 13GFeb 14, 2014SC 13GSC 13GFeb 14, 2014SC 13GSC 13GFeb 13, 2014SC 13GSC 13GFeb 13, 2014SC 13GSC 13GFeb 12, 2014
Similar companies
Comparable business profile · signals at a glance